Guangdong Association Of Clinical Trials

This study is testing whether combining two drugs, chidamide and ivonescimab, can help control advanced non-small cell lung cancer that has started growing again after initially responding to immunotherapy. It will involve about 32 adults whose tumors show high levels of a specif…

This study is testing whether a combination of four drugs can help control advanced lung cancer that has specific genetic changes and has stopped responding to standard targeted pills. About 61 adults with a high level of a protein called PD-L1 in their tumors will receive the dr…

This study looks back at the real-world use of the drug IBI351 in 600 Chinese patients with a specific, hard-to-treat form of advanced lung cancer (KRAS G12C mutation). The main goal is to see how well the drug worked in everyday clinical practice and how safe it was for patients…